Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial – medRxiv News Release: Study finds no benefit to taking fluticasone furoate for COVID-19 symptoms – Duke Clinical Research Institute Commentary: Asthma Drug Fluticasone Fails as Potential COVID-19 Treatment – HealthDay  

The post [PREPRINT] RCT | Inhaled fluticasone not beneficial for outpatients with Covid-19. appeared first on Links Medicus.